SAVA

Cassava Sciences, Inc. - Common Stock (SAVA)

About Cassava Sciences, Inc. - Common Stock (SAVA)

Cassava Sciences, Inc. engages in the development of novel drugs and diagnostics. It focuses on developing product candidates intended for the treatment of Alzheimer’s disease, including PTI-125 and PTI-125Dx. The company was founded by Remi Barbier in May 1998 and is headquartered in Austin, TX.

Details

Daily high

$2.10

Daily low

$2.04

Price at open

$2.08

52 Week High

$42.20

52 Week Low

$1.15

Market cap

100.0M

Dividend yield

0.00%

Volume

4,285

Avg. volume

846,465

P/E ratio

-1.37

Cassava Sciences, Inc. - Common Stock News